Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Acute Hereditary Angio Edema: later-stage trial registry

1 of 1 indexed Acute Hereditary Angio Edema trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Acute Hereditary Angio Edema: 1 US clinical trial tracked, 1 recruiting.

Acute Hereditary Angio Edema is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Octapharma, running 1 of these trials.

Enrollment posture brief

Registry condition acute-hereditary-angio-edema

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Acute Hereditary Angio E (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Acute Hereditary Angio Edema

Acute Hereditary Angio Edema lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Acute Hereditary Angio Edema on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Acute Hereditary Angio Edema is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

Octapharma 1 trials

Named interventions

Most-linked intervention names on Acute Hereditary Angio Edema records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

OCTA-C1-INH Drug
1 trials
Placebo Other
1 trials

US sites by state

Facility locations filed on Acute Hereditary Angio Edema trials. A trial with sites in several states counts in each.

Ohio 1 trials
Michigan 1 trials
Colorado 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Acute Hereditary Angio Edema page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Acute Hereditary Angio Edema trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Octapharma sponsors the most Acute Hereditary Angio Edema trials on record, review their full trial history before evaluating a specific study. See Octapharma's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acute Hereditary Angio Edema condition card totals 1 registered trials; most-linked intervention OCTA-C1-INH; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.